Evidence
Evidence & method
OXALIA's performance is assessed against a public, comparable, and verifiable methodology — never a marketing promise.
Methodology
Every performance figure will be published with its calculation method: dataset used, annotation protocol, inter-observer comparison. No figure is shared without this basis.
Sensitivity
—
Figure to be published with its method
Specificity
—
Figure to be published with its method
Productivity gain
—
Figure to be published with its method
Regulatory status
OXALIA is not currently CE-marked or FDA-cleared. Rather than hide that fact, we publish our path as it gets confirmed.
- Date to be confirmed
Current status
A clinical decision-support solution under development, not marketed as a certified medical device.
- Date to be confirmed
CE marking
Building the technical file for CE marking.
- Date to be confirmed
Clinical validation
Validation study at a pilot site, together with our institutional partners.